With Conditions, FTC Allows Cephalons Purchase of CIMA, Protecting Competition for Breakthrough Cancer Pain Drugs
Date
Under a consent agreement announced today, the Federal Trade Commission will allow Cephalon, Inc.’s $515 million acquisition of Cima Labs, Inc., provided that Cephalon grants Barr Laboratories, Inc. a...